ArchiMed to take Esperion Therapeutics private for $1.1bn
Friday, May 1, 2026 · first reported by PE Hub
ArchiMed to acquire Esperion Therapeutics for $1.1bn in take-private transaction, expected to close Q3 2026.
- Firm
- ArchiMed
- Also named
- Esperion Therapeutics
- Deal value
- $1.1B
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on ArchiMed
Everything on this firm →More in Deals
From the same day- AnaCap sells French private bank Milleis to LCL and Crédit Agricole AssurancesPE Hub
- Searchlight to invest in B2B events firm CloserStill MediaPE Hub
- Deals & Moves: Allworth Gets New PE Stake; $17B Mather Group AcquiresWealth Management
- Inflexion to acquire minority stake in Marktlink CapitalPE Hub
- David Hodes: ‘Why Chatham? They leaned in heavily on technology’PERE